Krystal Biotech Inc (KRYS)
177.39
-6.83
(-3.71%)
USD |
NASDAQ |
Nov 14, 16:00
177.41
+0.02
(+0.01%)
Pre-Market: 20:00
Krystal Biotech Net Income (TTM): 52.37M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 52.37M |
June 30, 2024 | 105.94M |
March 31, 2024 | 57.16M |
December 31, 2023 | 10.93M |
September 30, 2023 | -29.81M |
June 30, 2023 | -140.41M |
March 31, 2023 | -135.31M |
December 31, 2022 | -139.98M |
September 30, 2022 | -129.73M |
June 30, 2022 | -115.47M |
March 31, 2022 | -103.72M |
December 31, 2021 | -69.57M |
September 30, 2021 | -58.15M |
June 30, 2021 | -52.17M |
March 31, 2021 | -42.64M |
Date | Value |
---|---|
December 31, 2020 | -32.17M |
September 30, 2020 | -27.14M |
June 30, 2020 | -21.80M |
March 31, 2020 | -20.32M |
December 31, 2019 | -19.09M |
September 30, 2019 | -17.44M |
June 30, 2019 | -15.92M |
March 31, 2019 | -12.85M |
December 31, 2018 | -10.89M |
September 30, 2018 | -8.574M |
June 30, 2018 | -11.09M |
March 31, 2018 | -9.575M |
December 31, 2017 | -7.919M |
September 30, 2017 | -7.153M |
June 30, 2017 | -2.202M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-140.41M
Minimum
Jun 2023
105.94M
Maximum
Jun 2024
-45.55M
Average
-37.40M
Median
Net Income (TTM) Benchmarks
Bioventus Inc | -39.48M |
ADMA Biologics Inc | 68.13M |
Alnylam Pharmaceuticals Inc | -332.26M |
Amicus Therapeutics Inc | -104.69M |
Apellis Pharmaceuticals Inc | -250.10M |